Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $7.95 in the prior trading day, Teladoc Health Inc (NYSE: TDOC) closed at $8.16, up 2.64%. In other words, the price has increased by $2.64 from its previous closing price. On the day, 7.34 million shares were traded. TDOC stock price reached its highest trading level at $8.4093 during the session, while it also had its lowest trading level at $7.9.
Ratios:
Our goal is to gain a better understanding of TDOC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.94. For the most recent quarter (mrq), Quick Ratio is recorded 2.49 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Mizuho on July 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $10.
On November 15, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $14.
Jefferies reiterated its Hold rating for the stock on September 17, 2024, while the target price for the stock was revised from $8 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when DIVITA CHARLES III sold 16,787 shares for $7.59 per share. The transaction valued at 127,435 led to the insider holds 179,014 shares of the business.
DIVITA CHARLES III bought 16,787 shares of TDOC for $127,435 on Sep 11 ’25. On Sep 03 ’25, another insider, Rodrigues Fernando M., who serves as the President of BetterHelp of the company, sold 4,149 shares for $7.59 each. As a result, the insider received 31,491 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1441795712 and an Enterprise Value of 1797266816. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.57 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 0.707 whereas that against EBITDA is 95.184.
Stock Price History:
The Beta on a monthly basis for TDOC is 1.91, which has changed by -0.111111104 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is 6.33%, while the 200-Day Moving Average is calculated to be -3.82%.
Shares Statistics:
The stock has traded on average 6.46M shares per day over the past 3-months and 5773470 shares per day over the last 10 days, according to various share statistics. A total of 176.61M shares are outstanding, with a floating share count of 174.69M. Insiders hold about 1.13% of the company’s shares, while institutions hold 73.66% stake in the company. Shares short for TDOC as of 1757894400 were 23817885 with a Short Ratio of 3.68, compared to 1755216000 on 23618236. Therefore, it implies a Short% of Shares Outstanding of 23817885 and a Short% of Float of 15.079999999999998.
Earnings Estimates
The market rating for Teladoc Health Inc (TDOC) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.24 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.84 and -$1.35 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$0.96, with 4.0 analysts recommending between -$0.93 and -$0.99.
Revenue Estimates
23 analysts predict $625.66M in revenue for . The current quarter. It ranges from a high estimate of $629.95M to a low estimate of $619.6M. As of . The current estimate, Teladoc Health Inc’s year-ago sales were $640.51MFor the next quarter, 23 analysts are estimating revenue of $634.31M. There is a high estimate of $642.65M for the next quarter, whereas the lowest estimate is $621.4M.
A total of 24 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.53B, while the lowest revenue estimate was $2.5B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 24 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.49B.
